CSX
60
3
YUM
47
3
NAVI
52
5
CA
38
6
BWA
48
2
EL
25
4
KMI
67
-2
LEG
36
4
CINF
53
2
CAH
48
-5
LB
63
22
ADT
53
3
WU
32
2
MAT
46
12
BA
54
5
DOW
44
10
HPE
63
2
DG
6
2
FLR
58
3
AN
58
4
CSX
60
3
YUM
47
3
NAVI
52
5
CA
38
6
BWA
48
2
EL
25
4
KMI
67
-2
LEG
36
4
CINF
53
2
CAH
48
-5
LB
63
22
ADT
53
3
WU
32
2
MAT
46
12
BA
54
5
DOW
44
10
HPE
63
2
DG
6
2
FLR
58
3
AN
58
4
Financhill
Back

Akari Therapeutics PLC Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
10

AKTX
Akari Therapeutics PLC

Last Price:
1.30
Seasonality Move:
-10.36%
Sell
27

ASND
Ascendis Pharma AS

Last Price:
130.01
Seasonality Move:
20.86%
Sell
10
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $1.30. The Score for AKTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $129.81. The Score for ASND is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $1.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $129.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 26.66 Sell
Chaikin Money Flow: 110616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.81 - 2.57) Sell
Bollinger Bands (100): (2.43 - 3.73) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.53 Sell
Relative Strength Index (14 RSI): 53.83 Buy
Chaikin Money Flow: 334016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.01 - 129.03) Buy
Bollinger Bands (100): (124.29 - 141.45) Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.8 Sell
20-day SMA: 2.18 Sell
50-day SMA: 2.57 Sell
200-day SMA: 2.53 Sell
8-day EMA: 1.7 Sell
20-day EMA: 2.05 Sell
50-day EMA: 2.47 Sell
200-day EMA: 2.91 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.01 Buy
20-day SMA: 125.87 Buy
50-day SMA: 133.06 Sell
200-day SMA: 136.78 Sell
8-day EMA: 125.66 Buy
20-day EMA: 126.61 Buy
50-day EMA: 129.57 Buy
200-day EMA: 130.24 Sell

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $4.01 per share.

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):